Navigation Links
A new analysis method allows to find out the sex of the baby from the second month of pregnancy

The spin off of the University of Granada Lorgen, in collaboration with the Foetal Medicine Unit of the Maternity Hospital Virgen de las Nieves of Granada, has managed to develop a genetic trial that identifies the sex of the foetus from the eighth week of pregnancy separating the DNA found in the plasma of the pregnant woman. This new finding has been tested through a clinical trial in 120 pregnant women, under the coordination Dr Sebastin Manzanares (Foetal Medicine Unit of the Virgen de las Nieves University Hospital). The methods effectiveness rate is above 98%. Although the test can be carried out from the sixth week of pregnancy, the reliability of the technique is much higher from the eighth.

The technique is based on the fact that, during pregnancy, between 3.4 and 6.2% of the total DNA free in mother plasma has a foetal origin. Therefore, a simple peripheral blood sample is enough for the study, which opens new possibilities in the field of non-invasive prenatal diagnosis.

With all these privacy guarantees, the mother can carry out the extraction directly through a simple method, send it to Lorgen and receive the results 48 hours later.

Diagnosis of monogenic diseases

This new process, apart from saving the parents the wait until the forth or fifth month of pregnancy to find out the sex of their future baby, involves a great scientific progress with important medical applications; especially in the diagnosis of monogenic diseases related to X chromosome, such as haemophilia or Duchenne muscular dystrophy. In these cases, the possibility of determining the sex of the baby as soon as possible, would avoid the processes of invasive prenatal diagnosis such as amniocentesis, chorionic villus biopsy or cordcentesis, which involve a danger for the life of the foetus.

Genetic research and molecular biology

The research work has been sponsored by the Foundation for Biosanitary Research of Eastern Andalusia Alejandro Otero (FIBAO). Lorgen GP is a pioneer company in the field of genetic research and molecular biology created as spin off of the University of Granada by Professor Jos Antonio Lorente Acosta, director of the Laboratory of Genetic Identification of the UGR. Lorgen is one of the business initiatives sponsored by the investment holding of Granada Lider and made up by 24 businessmen and 2 financial entities (CajaGranada and Caja Rural de Granada).


Contact: Javier Valverde
Universidad de Granada

Related biology news :

1. Ginkgo SRMs: Tools for product analysis/quality
2. DNA analysis shows true dispersal of protozoa
3. Interacting protein theory awaits test from new neutron analysis tools
4. Analysis of breast and colon cancer genes finds many areas of differences between tumors
5. Tumor genome analysis unveils new insights into lung cancer
6. Powerful integration of lipid metabolic profiling with gene expression analysis
7. Human clones: New U.N. analysis lays out worlds choices
8. More comprehensive analysis of Klamath River basin needed to aid decision makers
9. Analysis calls for medical device information to better serve patients and doctors
10. Avian origins: new analysis confirms ancient beginnings
11. DOE JGI releases a new version of its metagenome data management and analysis system
Post Your Comments:
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:10/29/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that it has been selected ... of only three finalists for a 2015 Tekne ... category. The Tekne Awards honor Minnesota ... and leadership. iMedNet™ eClinical  technology ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , November 24, 2015 SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Financial Officer, will participate in the Piper Jaffray 27 th ... NY on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading ... culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... on the management team and was promoted to Head of InSphero Diagnostics ...
(Date:11/24/2015)... 24, 2015 Capricor Therapeutics, Inc. ... the discovery, development and commercialization of first-in-class therapeutics, today ... Officer, is scheduled to present at the 2015 Piper ... a.m. EST, at The Lotte New York Palace Hotel ... . --> . ...
Breaking Biology Technology: